9/23/2026
Psyence BioMed announces ibogaine investment and trial plans
Psyence BioMed to invest $5M in PsyLabs, plans Texas ibogaine trial.
Topic archive
2 stories
9/23/2026
Psyence BioMed to invest $5M in PsyLabs, plans Texas ibogaine trial.
8/19/2026
Company aligns with U.S. efforts to advance ibogaine research.